FDA Watch: The Most Impactful Drug Approvals in 2024

The FDA approved 55 drugs in 2023, including the highly anticipated Lecanemab by Eisai (ESAIY) and Biogen (BIIB), GSK’s (GSK) world-first vaccine for respiratory syncytial virus (RSV), Zurzuvae, the first oral postpartum depression treatment by Biogen and Sage Therapeutics (SAGE), and Pfizer’s (PFE) Velsipity for ulcerative colitis. 15 drugs have now received a nod from… [Read More]

AIM ImmunoTech Combination Therapy Well Tolerated in Late-Stage Pancreatic Cancer

AIM ImmunoTech’s (NYSE American: AIM) combination therapy for the treatment of late-stage pancreatic cancer has demonstrated safety and tolerability in a Phase 1b/2 study being conducted by the company in the Netherlands. No treatment-related severe adverse events or dose-limiting toxicities were noted by investigators at the Erasmus Medical Center, which is collaborating with AIM on… [Read More]
Asian mother breastfeeding baby at home.

Vaxart Reports Positive Topline Results in Norovirus Vaccine Trial in Lactating Women

Vaxart, Inc. (Nasdaq: VXRT) has reported positive topline results from a Phase 1 clinical trial evaluating its oral pill bivalent norovirus vaccine candidate in lactating women. The company’s long-term goal is to provide protection to infants through passive antibody transfer through their mother’s breast milk. Vaxart’s share price settled up 6.91% in trading on Thursday… [Read More]
Solar panels on the roof of the modern family houses

Sunrun Supports Puerto Rico with Dependable Solar Energy

Clean energy provider, Sunrun (Nasdaq: RUN), has announced that it has enrolled nearly 1,800 customers in its PowerOn Puerto Rico virtual power plant. Sunrun, which has a market cap of $2.42 billion, saw its stock rise 8.74% in intraday trading on Thursday following the news. Sunrun has partnered with Puerto Rico’s electric utility provider, LUMA,… [Read More]

Microsoft and Brookfield Ink Historic Clean Energy Deal

In a landmark move for corporate clean energy, Microsoft Corp.(MSFT) has teamed up with Brookfield Asset Management’s (BAM) renewable division to sign the largest-ever corporate clean-energy purchase agreement. Starting in 2026, Brookfield Renewable Partners will supply Microsoft with over 10.5 gigawatts of renewable energy across the US and Europe, an amount of power equivalent to… [Read More]

Metagenomi Shares Drop as Moderna Collaboration Terminated

Metagenomi Inc’s (Nasdaq: MGX) share price dropped by almost 12.0% in intraday trading on Thursday after the company announced that it had mutually agreed to terminate a collaboration with Moderna (Nasdaq: MRNA). Moderna’s shares soared 15.09% following the news. Moderna currently owns 4.5% of the company and will continue to be a shareholder of Metagenomi’s… [Read More]

Sunnova Stock Shines, Jumps 22% on Earnings Beat

Sunnova Energy International (NYSE: NOVA) stock soared 22% this morning, following a surprising earnings report last night that surpassed Wall Street expectations. While analysts had predicted a loss of $0.73 per share on sales of $194.9 million for the first quarter of 2024, Sunnova reported a narrower loss of $0.57 per share on revenue of… [Read More]

Tech Stocks Rally Ahead of Apple’s Earnings and Upcoming Jobs Report

The anticipation of Apple Inc.’s earnings report and the upcoming Friday employment data spurred a rebound in the stock market, led by the world’s largest technology companies. Equities recovered from a two-day drop, with notable gains from Nvidia Corp. in the chip sector and a nearly 2% increase in Apple shares. Investors are hopeful for… [Read More]

Actelis Networks Secures $2.3 Million Order

Leading networking solutions company, Actelis Networks (Nasdaq: ASNS) has secured an order for approximately $2.3 million to supply Washington D.C.’s Department of Transportation (DDOT) with a new hybrid-fiber intelligent networking solution for the city’s transportation network. The company’s total revenues in 2023 were $5.6 million, and this substantial order represents a significant springboard for potential… [Read More]